Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?
about
Mesenchymal stem cells provide prophylaxis against acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: A meta-analysis of animal modelsTbet is a critical modulator of FoxP3 expression in autoimmune graft-versus-host diseasePirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.Novel targets in the treatment of chronic graft-versus-host disease.Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment.Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease.Simple, Reproducible, and Efficient Clinical Grading System for Murine Models of Acute Graft-versus-Host Disease.Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers.Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.B-cell targeting in chronic Graft-versus-Host disease.Cytokine mediators of chronic graft-versus-host disease.Bat-mouse bone marrow chimera: a novel animal model for dissecting the uniqueness of the bat immune system.Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host disease.Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease.
P2860
Q37641684-F303525F-5ED1-4A4E-9D44-BCB2A9023EFEQ38803247-624B1A01-6675-48EE-A185-404126852795Q38932342-13516493-832A-49C1-B240-A463CE9E4222Q39023963-CEB8FD53-C93A-471D-A0A3-0907A4DB3632Q40385568-41A8EB5C-961E-4F60-A169-999014CC9B4BQ46458062-6F784E8C-C3BE-48ED-9696-749E7314F421Q49215746-27DB47DE-325C-4035-83DB-180E4A6280D4Q49464975-C209A25A-1076-408F-A181-9D4C8997A57BQ49679320-ED3880B9-5768-4DB6-BDFD-D2DA54023E64Q49954477-E7855230-EE5A-43B6-9BE2-53404E600098Q50044417-7D4E8302-D6A9-4EDF-A279-36DD597FA2B9Q50915048-20ED9E41-FE60-4636-AB98-B9B521CB428CQ52651200-ADD78412-002F-4D33-9781-6D3EB791D54DQ55260254-E60176AE-A6D0-4936-86D8-640C99822F88Q55375763-821DF4DF-5733-49CF-A88F-70025D21BF2D
P2860
Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preclinical models of acute an ...... ccessful clinical translation?
@en
Preclinical models of acute an ...... ccessful clinical translation?
@nl
type
label
Preclinical models of acute an ...... ccessful clinical translation?
@en
Preclinical models of acute an ...... ccessful clinical translation?
@nl
prefLabel
Preclinical models of acute an ...... ccessful clinical translation?
@en
Preclinical models of acute an ...... ccessful clinical translation?
@nl
P2860
P1433
P1476
Preclinical models of acute an ...... ccessful clinical translation?
@en
P2093
Robert Zeiser
P2860
P304
P356
10.1182/BLOOD-2016-02-699082
P407
P577
2016-03-18T00:00:00Z